PathoQuest and Covance to Offer NGS-based Biosafety Assessments

News   Nov 07, 2013

 
PathoQuest and Covance to Offer NGS-based Biosafety Assessments
 
 
 
 

RELATED ARTICLES

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors Spread

News

Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.

READ MORE

Edith Heard Unanimously Selected as Next Director General of EMBL

News

At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE